PPI Therapy for Peptic Ulcer Disease
For uncomplicated peptic ulcers, use standard-dose PPI twice daily (e.g., omeprazole 20 mg, lansoprazole 30 mg, pantoprazole 40 mg, or rabeprazole 20 mg) for 4-8 weeks depending on ulcer type—duodenal ulcers require 2-4 weeks while gastric ulcers need 4-8 weeks. 1
Initial Management Based on Ulcer Type and Complications
Bleeding Peptic Ulcers with High-Risk Stigmata
For patients with active bleeding or visible vessel who undergo successful endoscopic therapy:
- Initiate high-dose IV PPI immediately: 80 mg bolus followed by 8 mg/hour continuous infusion for 72 hours (3 days) 2
- After 72 hours of IV therapy: Switch to oral PPI 40 mg twice daily for 11 days (completing 14 days total) 3
- Continue with: PPI 40 mg once daily for an additional 2 weeks 3
This high-dose regimen reduces rebleeding risk by 63% compared to once-daily dosing (RR 0.37) 3. The continuous infusion is critical because it maintains the sustained high gastric pH needed for clot stabilization—intermittent dosing cannot reliably achieve this 4.
Uncomplicated Peptic Ulcers
Duodenal ulcers: Standard-dose PPI twice daily for 2-4 weeks 1
Gastric ulcers: Standard-dose PPI twice daily for 4-8 weeks (longer duration needed due to slower healing) 1
Standard doses are:
- Omeprazole 20 mg twice daily
- Lansoprazole 30 mg twice daily
- Pantoprazole 40 mg twice daily
- Rabeprazole 20 mg twice daily
H. pylori Management
All patients with peptic ulcers must be tested for H. pylori using urea breath test (sensitivity 88-95%, specificity 95-100%) or stool antigen test (sensitivity 94%, specificity 92%) 2.
If H. pylori Positive:
First-line therapy (in areas with low clarithromycin resistance):
- PPI standard dose twice daily
- Clarithromycin 500 mg twice daily
- Amoxicillin 1000 mg twice daily
- Duration: 14 days 2
Start this triple therapy after completing 72-96 hours of IV PPI in bleeding ulcers 2.
Alternative first-line (if high clarithromycin resistance or compliance assured):
- Sequential 10-day therapy: PPI + amoxicillin 1000 mg twice daily for 5 days, then PPI + clarithromycin 500 mg + metronidazole 500 mg twice daily for 5 days 2
Second-line therapy (if first-line fails):
- PPI standard dose twice daily
- Levofloxacin 500 mg once daily (or 250 mg twice daily)
- Amoxicillin 1000 mg twice daily
- Duration: 10 days 2
H. pylori eradication reduces rebleeding rates from 26% to near-zero 2. This is the single most important intervention for preventing ulcer recurrence.
NSAID-Associated Ulcers
If NSAIDs can be discontinued: Stop NSAID and treat with standard-dose PPI twice daily for 4-8 weeks 5
If NSAIDs must continue: Use PPI therapy throughout NSAID use 5
Prevention in patients with ulcer history requiring NSAIDs: PPIs with or without switching to celecoxib 5
Prevention in patients with ulcer history requiring low-dose aspirin: PPIs are recommended; H2-receptor antagonists are suggested as alternative 5
The evidence shows PPIs heal significantly more NSAID-associated ulcers in 8 weeks compared to H2-receptor antagonists 6.
H. pylori-Negative, Non-NSAID Ulcers (Idiopathic)
These ulcers are more aggressive with higher recurrence and bleeding risk compared to H. pylori-positive ulcers 6.
Management: Long-term maintenance PPI therapy may be necessary 6. Use standard-dose PPI once daily indefinitely after initial healing course.
PPI Intolerance or Contraindications
If PPIs cannot be used:
- H2-receptor antagonists are less effective but acceptable alternatives 1
- For H. pylori-negative ulcers without H. pylori infection or after successful eradication, H2RAs showed no significant difference from PPIs in one trial 3
- However, this is suboptimal—attempt different PPI formulations or vonoprazan (if available) before abandoning PPI class entirely 5
Critical Pitfalls to Avoid
Do not use once-daily PPI for high-risk bleeding ulcers—twice-daily dosing after initial IV therapy reduces rebleeding by 63% 3
Do not skip H. pylori testing—35% of patients have inappropriate long-term PPI use when the underlying cause isn't addressed 7
Do not continue PPIs indefinitely without indication—35% of PUD patients receive PPIs beyond approved duration for median 346 days 7. Reassess at 8 weeks.
Do not use empiric H. pylori eradication without testing—confirm infection first, as regional prevalence varies and unnecessary antibiotics promote resistance 2
Gastric ulcers need longer treatment than duodenal ulcers—4-8 weeks vs 2-4 weeks 1
Duration Summary
- Bleeding ulcers (high-risk): 72 hours IV high-dose → 11 days oral twice-daily → 2 weeks once-daily = 4 weeks total
- Duodenal ulcers: 2-4 weeks
- Gastric ulcers: 4-8 weeks
- H. pylori eradication: 14 days (with PPI)
- NSAID ulcers with continued NSAID use: Ongoing PPI therapy
- Idiopathic ulcers: Consider long-term maintenance